Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 901–1,000 of 1,000
Weeks, J. M., Motsinger‐Reif, A. A., & Reems, M. M. (2020) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.13020 · Cited by 9
Maruti, P., Musyoki, S., & Amayo, A. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.280.22327 · Cited by 9
McMullin, N. R., Holcomb, J. B., & Sondeen, J. L. (2006) · Yearbook of intensive care and emergency medicine · doi:10.1007/3-540-33396-7_25 · Cited by 9
Fetal-like Hemoglobin in Sickle Cell Anemia
Steinberg, M. H. (2022) · New England Journal of Medicine · doi:10.1056/nejme2119760 · Cited by 11
Ussher, F. A., Laing, E. F., Atta-Owusu, A. B., Kontor, E. K., Jain, N., Lokpo, S. Y., Adu, E. A., Ametepe, S., Tetteh, R., Dei‐Adomakoh, Y., et al. (2025) · Journal of sickle cell disease. · doi:10.1093/jscdis/yoaf020 · Cited by 8
Single cell analysis of aged RBCs: quantitative analysis of the aged cells and byproducts
Kim, J., Weigand, M., Palmer, A. F., Zborowski, M., Yazer, M. H., & Chalmers, J. J. (2018) · The Analyst · doi:10.1039/c8an01904e · Cited by 9
Njoku, F. U., Zhang, X., Shah, B. N., Han, J., Machado, R. F., Saraf, S. L., & Gordeuk, V. R. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117223 · Cited by 9
Laila, I. M. I., Kassem, S., & Diab, M. S. E. M. (2023) · Laboratory Animal Research · doi:10.1186/s42826-023-00173-4 · Cited by 12
“NO levels were estimated using the Griess reaction [95].”
MethodIrwin, D. C., Calvo, E. T. N., Belbis, M. D., Ehrenfort, S. K. C., Noguer, M., Messonnier, L. A., Buehler, P. W., Hirai, D. M., & Ferguson, S. K. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00390.2024 · Cited by 8
Arnhold, J. (2025) · Biomolecules · doi:10.3390/biom15040547 · Cited by 8
“A decreased bioavailability of NO is observed by enhanced processes of intravascular hemolysis from red blood cells or rhabdomyolysis from damaged muscles [221,302].”
Pathophysiology and physical activity in patients with sickle cell anemia
Waltz, X., & Connes, P. (2014) · Movement & Sport Sciences - Science & Motricité · doi:10.1051/sm/2013105 · Cited by 8
Polyunsaturated Fatty Acid and Sphingolipid Measurements by Tandem Mass Spectrometry
Aslan, M. (2020) · Mini-Reviews in Organic Chemistry · doi:10.2174/1570193x17999200504094901 · Cited by 9
Cardiac pathophysiology in sickle cell disease
Gbotosho, O. T., Taylor, M. D., & Malik, P. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02414-6 · Cited by 8
“Oxidative membrane damage and repeated sickling and unsickling of RBC results in chronic intravascular and extravascular hemolysis, resulting in anemia [4, 5].”
BackgroundAlishlash, A. S., Sapkota, M., Ahmad, I., Maclin, K. M., Ahmed, N. A., Molyvdas, A., Doran, S. F., Albert, C. J., Aggarwal, S., Ford, D. A., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102009 · Cited by 8
Clinical and Pathophysiological Aspects of Sickle Cell Anemia
Steinberg, M. H., Ohene‐Frempong, K., & Heeney, M. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.027 · Cited by 9
Waugh, W. H. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200310000-00021 · Cited by 8
“hemoglobin and other heme species, by conversion to ferrihemes.(4,5) Plasma or serum myeloperoxidase levels from acti-”
BackgroundSullivan, I. J., & Faulds, J. N. (2014) · Transfusion Medicine · doi:10.1111/tme.12147 · Cited by 8
“It has been suggested that 0·1 g L−1 free Hb significantly impairs NO metabolism, levels greater than 0·16 g L−1 are linked to renal injury/dysfunction and greater than 1·0 g L−1 may cause haemoglobinuria (Widman, 1989; Reiter et al., 2002).”
BackgroundHemolytic vascular inflammation: an update
Conran, N., & Almeida, C. B. (2015) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2015.10.004 · Cited by 10
Sickle Cell Disease – Current Treatment and New Therapeutical Approaches
de Melo, T. R. F., Ercolin, L. D. R., Chelucci, R. C., Melchior, A. C. B., Lanaro, C., Chin, C. M., & dos Santos, J. L. (2015) · InTech eBooks · doi:10.5772/60515 · Cited by 8
“(NO) molecules present in the vascular endothelium, generating a “vasoconstriction effect” in the patient [13].”
BackgroundShriner, D., Kumkhaek, C., Doumatey, A. P., Chen, G., Bentley, A. R., Charles, B. A., Zhou, J., Adeyemo, A., Rodgers, G. P., & Rotimi, C. N. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0249-z · Cited by 8
“Cell-free hemoglobin also limits nitric oxide bioavailability [54, 55].”
BackgroundPostprandial lipids accelerate and redirect nitric oxide consumption in plasma
Vrancken, K., Schroeder, H. J., Longo, L. D., Power, G. G., & Blood, A. B. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.03.004 · Cited by 10
Vilas-Boas, W., Figueiredo, C. V. B., Pitanga, T. N., Carvalho, M. O. S., Santiago, R. P., Santana, S. S., da Guarda, C. C., Zanette, Â., Cerqueira, B. A. V., & Gonçalves, M. D. S. (2016) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s38276 · Cited by 8
Targeting the vascular dysfunction: Potential treatments for preeclampsia
Marshall, S. A., Langston‐Cox, A., Parry, L. J., & Wallace, E. M. (2018) · Microcirculation · doi:10.1111/micc.12522 · Cited by 8
Zhao, L., Zhang, H., Zhang, J., Zong, W., & Liu, R. (2019) · Luminescence · doi:10.1002/bio.3607 · Cited by 8
Depletion of Vascular Nitric Oxide Contributes to Poor Outcomes after Cardiac Arrest
Hayashida, K., Miyazaki, Y., Yu, B., Silverman, M. G., Pinciroli, R., Berra, L. M., Malhotra, R. K., Donnino, M. W., & Ichinose, F. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201812-2377le · Cited by 8
“Vascular NO consumption by plasma Oxy-Hb has been implicated in the pathogenesis of a variety of human diseases, including vaso-occlusive crisis in sickle cell anemia (8), adverse effects of transfusion of Hb-based oxygen carrier (9), Table 1.”
BackgroundOkumura, J. V., da Silva, D. G. H., Torres, L. S., Belini-Junior, E., Barberino, W. M., de Oliveira, R. G., Carrocini, G. C. S., Gelaleti, G. B., Lobo, C. L. C., & Bonini-Domingos, C. R. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.16 · Cited by 10
Maraprygsavan, P., Mongkolsuk, J., Arnhold, J., & Kuehne, F.-W. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.05.001 · Cited by 9
“This improves the bioavailability of nitricmonoxide and blood circulation, because nitric monoxide cannot further be utilized by hemolytic hemoglobin [9,42,43].”
BackgroundTarasev, M., Muchnik, M., Light, L., Alfano, K. M., & Chakraborty, S. (2016) · Translational research · doi:10.1016/j.trsl.2016.09.005 · Cited by 9
Pereira, D. A., Pereira, D. A., Silveira, T. H. R., Calmasini, F. B., Burnett, A. L. “., Costa, F. F., & Silva, F. H. (2024) · Andrology · doi:10.1111/andr.13599 · Cited by 7
Brooks, S., Ruhl, A. P., Zeng, X., Cruz, P., Hassan, S. A., Kamenyeva, O., Hakim, M. A., Ridley, L. A., Nagata, B. M., Kabát, J., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.066003 · Cited by 8
“27–29 Based on the studies presented herein, we propose that sickle cell trait, in which an amino acid substitution disrupts the interactions of beta globin with eNOS, and alpha thalassemia, in which vascular expression of alpha globin is decreased, both converge on a common phenotype of increased…”
Novel Therapies Targeting the Endothelium in Sickle Cell Disease
Hoppe, C. C. (2011) · Hemoglobin · doi:10.3109/03630269.2011.606482 · Cited by 8
Selective renal blood perfusion induces renal tubules injury in a porcine model
Kalder, J., Kokozidou, M., Keschenau, P. R., Tamm, M., Greiner, A., Koeppel, T. A., Tolba, R. H., & Jacobs, M. J. H. M. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.08.116 · Cited by 7
Presumptive Ischemic Brain Infarction in a Dog with Evans’ Syndrome
Giannuzzi, A. P., Simone, A. D., Ricciardi, M., & Gernone, F. (2014) · Case Reports in Veterinary Medicine · doi:10.1155/2014/456524 · Cited by 7
Red blood cell deformability is reduced in homozygous sickle cell disease patients with leg ulcers
Bowers, A. S., Duncan, W. W., & Pepple, D. J. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-162063 · Cited by 7
“Sickle cell disease is associated with numerous cellular abnormalities including defective membrane proteins, dysfunctional lipid bilayer, iron decompartmentalization and abnormal cell-cell interactions [12, 22, 31].”
Calabrò, E., & Magazù, S. (2017) · Bioelectromagnetics · doi:10.1002/bem.22056 · Cited by 7
“However, too much NO is toxic for living organisms, and loss of NO can induce various diseases such as sickle cell disease and endothelial dysfunctions [Reiter et al., 2002; Frisbee, 2005].”
BackgroundTroponin Elevation in Sickle Cell Disease
Akkuş, N. İ., Rajpal, S., Hilbun, J., Dwary, A. D., Smith, T. R., Mina, G. S., & Reddy, P. C. (2021) · Medical Principles and Practice · doi:10.1159/000517540 · Cited by 7
“Markers for hemolysis are associated with reduced nitric oxide availability [16], endothelial dysfunction [17], and pulmonary hypertension [18, 19] suggesting the link between hemolysis, the hemolytic rate and sickle vasculopathy [20].”
BackgroundInflammation-Associated Cytotoxic Agents in Tumorigenesis
Arnhold, J. (2023) · Cancers · doi:10.3390/cancers16010081 · Cited by 8
“An overexpression of SOD3 also a tt enuates the activity of MMPs and heparinase, which are involved in matrix degradation, angiogenesis, and metastasis [403]. contributes to a reduced bioavailability of NO as the oxidation of hemoglobin to methe-moglobin is usually promoted by NO [283,284].”
BackgroundDomizi, R., Damiani, E., Carsetti, A., Graciotti, L., Procopio, A. D., Scorcella, C., Casarotta, E., Giaccaglia, P., Donati, A., & Adrario, E. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01251-z · Cited by 7
Hannemann, A., Cytlak, U., Robert, J., Ellory, J. C., David, C., & John, S. (2011) · InTech eBooks · doi:10.5772/24426 · Cited by 7
“…al., 1980; Eaton & Hofrichter, 1987), together with altered nitric oxide scavenging by haemoglobin following intravascular haemolysis (Hebbel, 1991; Reiter et al., 2002; Gladwin et al., 2004; Kato et al., 2006) and also release of inflammatory cytokines (Setty et al., 2008; Setty & Betal, 2008),…”
Zhang, X., Liu, C., Yuan, Y., Zhang, S., Shan, X., Sheng, Y., & Xu, F. L. (2008) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-007-3358-1 · Cited by 8
Wang, Y., Zhang, Y., Zhao, L., Yin, Y., Wang, Q., & Zhou, H. M. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.020 · Cited by 8
Dickerson, R. N., Maish, G. O., Weinberg, J. A., Croce, M. A., Minard, G., & Brown, R. O. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613483840 · Cited by 8
Rammos, C., Zeus, T., Balzer, J., Kubatz, L., Hendgen-Cotta, U. B., Veulemans, V., Hellhammer, K., Totzeck, M., Luedike, P., Kelm, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151203 · Cited by 7
“Mechanistically, such subclinical hemolysis leads to Hb scavenging of NO, which has been shown to abrogate vascular functions during hemodialysis or in sickle cell anemia [8, 9].”
BackgroundRed Blood Cells and the Vaso-Occlusive Process
Wandersee, N. J., & Hillery, C. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_4 · Cited by 11
Wang, L., Almeida, L. E. F., Kamimura, S., van der Meulen, J. H., Nagaraju, K., Quezado, M., Wakim, P., & Quezado, Z. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.08.005 · Cited by 8
“One such factor is hemolysis leading to release of free hemoglobin, which rapidly reacts with and scavenges NO [17; 18].”
BackgroundGladwin, M. T., & Kato, G. J. (2007) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-6.1.23 · Cited by 7
Self-citationRapid vs. delayed infrared responses after ischemia reveal recruitment of different vascular beds
Chang, K., Yoon, S. P., Sheth, N., Seidel, M., Antalek, M. D., Ahad, J., Darlington, T., Ikeda, A. K., Kato, G. J., Ackerman, H. C., et al. (2015) · Quantitative InfraRed Thermography Journal · doi:10.1080/17686733.2015.1046677 · Cited by 7
“Sickled cells also alter endothelium-dependent events, with mechanisms including diminished vasodilation in response to shear stress and diminished response to nitric oxide due to cell-free ferrous hemoglobin in the plasma [3, 4].”
BackgroundGolenkina, E. A., Galkina, S. I., Romanova, J. M., LAZARENKO, M. I., & Sud’ina, G. F. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02786.x · Cited by 7
“Cell-free haemoglobin consumes NO 1000 times more rapidly than RBCs (41), which can”
BackgroundPlasma chitotriosidase and carotid intima–media thickness in children with sickle cell disease
Kaddah, N., Saied, D. A., Al-Wakeel, H. A., Hashem, R. H., Rowizak, S. M., & Elmonem, M. A. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2288-z · Cited by 7
Serrano, K., Pambrun, C., Levin, E., & Devine, D. V. (2017) · Transfusion · doi:10.1111/trf.14270 · Cited by 7
“fHb is a scavenger of nitric oxide (NO); depletion of NO leads to vasoconstriction with decreased tissue and organ perfusion, most notably decreased kidney perfusion.(8,9) Microvesicles also increase after irradiation and RBC storage and may be proinflammatory and procoagulant in recipients.”
BackgroundLeong, K. W., Singh, K. P., Leder, K. S., & Tong, S. Y. C. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-237501 · Cited by 7
Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches
Guerrero‐Hue, M., Rubio‐Navarro, A., Sevillano, Á., Yuste, C., Gutiérrez, E., Palomino‐Antolín, A., Román, E., Praga, M., Egido, J., & Moreno, J. A. (2018) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2018.01.003 · Cited by 10
Low grade intravascular hemolysis associates with peripheral nerve injury in type 2 diabetes
Jeune, S. L., Sadoudi, S., Charue, D., Abid, S., Guigner, J., Helley, D., Bihan, H., Baudry, C., Lelong, H., Mirault, T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275337 · Cited by 7
Hemoglobin Serves to Protect Plasmodium Parasites from Nitric Oxide and Reactive Oxygen Species
Sobolewski, P., Gramaglia, I., Frangos, J. A., Intaglietta, M., & van der Heyde, H. C. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.53507 · Cited by 7
Sickle Cell Disease–associated Pulmonary Hypertension
McLaughlin, V. V., & Channick, R. N. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-478ed · Cited by 7
Zhang, C., Song, Z., Zhao, Y., Guo, X., Huang, T., Guo, Y., Ma, J., Zhang, C., Chen, J., & He, Y. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111709 · Cited by 6
Evaluation and management of pulmonary hypertension in the emergency department setting
Simon, E., Bridwell, R. E., Montrief, T., Koyfman, A., & Long, B. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.02.041 · Cited by 6
Myeloproliferative Neoplasms: Challenging Dogma
Spivak, J. L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226957 · Cited by 8
Heme-mediated selection of encapsulated Streptococcus pneumoniae in the lungs by oxidative stress
Alibayov, B., Vidal, A. G. J., Murin, L., Scasny, A., Takeshita, K., Beeton, K., Edwards, K. S., Punshon, T., Jackson, B. P., McDaniel, L. S., et al. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2532685 · Cited by 7
Doppler-defined pulmonary hypertension in β-thalassemia major in Kurdistan, Iraq
Mohammad, A. M., Dawad, M. M., Kashmoola, M. A., & Al-Allawi, N. A. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243648 · Cited by 6
“Hemolysis would lead to release of cell-free hemoglobin and arginase and thus lead to impaired nitric oxide availability and endothelial dysfunction and eventually pulmonary hypertension, and this has documented in both sickle cell anemia and thalassemia [39, 40].”
BackgroundLiu, T., Zhu, F., Tan, N., Chen, S., & Xu, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00012-5 · Cited by 6
Hereditary TTP/Upshaw–Schulman syndrome: the ductus arteriosus controls newborn survival
Fujimura, Y. (2024) · International Journal of Hematology · doi:10.1007/s12185-024-03731-1 · Cited by 6
Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease
Igbineweka, N. E., & van Loon, J. J. W. A. (2024) · npj Genomic Medicine · doi:10.1038/s41525-024-00427-7 · Cited by 7
HCAR2 is a novel receptor for heme
Grünenwald, A., Peliconi, J., Zarantonello, A., Dimitrov, J. D., Roumenina, L. T., & Merle, N. S. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025016197 · Cited by 7
Johnson, M. C., Johnikin, M. J., Euteneuer, J. C., DeBaun, M. R., & Hildebolt, C. F. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25239 · Cited by 6
“In patients with SCD, inflammation could be a factor in coronary artery dilation but nitric oxide bioavailability is thought to be limited [29,30].”
BackgroundHypertension artérielle pulmonaire et drépanocytose
Savale, L., Maître, B., Bachir, D., Galactéros, F., Simonneau, G., & Parent, F. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.04.021 · Cited by 6
The Current State of Imaging Pediatric Hemoglobinopathies
Dinan, D., Epelman, M. S., Guimaraes, C. V. A., Donnelly, L. F., Nagasubramanian, R., & Chauvin, N. A. (2013) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2013.05.005 · Cited by 6
Dekker, D., Dorresteijn, M. J., Peters, W. H. M., Bilos, A., Pennings, S. W. C., Wagener, F. A. D. T. G., & Smits, P. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115605047 · Cited by 7
Sickle cell-induced ischemic priapism
AlDallal, S. M., AlDallal, N. M., & Alam, A. A. A. (2016) · Cogent Medicine · doi:10.1080/2331205x.2016.1268357 · Cited by 6
Therapeutic options for chronic kidney disease-associated pulmonary hypertension
Edmonston, D. L., & Sparks, M. A. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000624 · Cited by 8
Red-Colored Urine in the Cardiac Surgical Patient—Diagnosis, Causes, and Management
Koh, L. Y., & Hwang, N. C. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.10.014 · Cited by 6
William, N., Bicahlo, B., Hansen, A. L., de Korte, D., Acker, J. P., & Collaborative, B. E. F. S. T. (. (2022) · Transfusion · doi:10.1111/trf.16809 · Cited by 6
“This could be a particular concern in patients with sickle cell disease who require irradiated RCCs as a high intrinsic concentration of decompartmentalized Hb is characteristic of this condition.(14) Thus, the aim of the present study was to evaluate the impact of irradiation and its timing on the state of extracellu…”
BackgroundLewis, C., Sellak, H., Hansen, L., Joseph, G., Hurtado, J., Archer, D. R., Jun, H., Brown, L. A. S., & Taylor, W. R. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00780-0 · Cited by 6
Ruiz, M. A., Shah, B. N., Ren, G., Hussain, F. A., Njoku, F. U., Machado, R. F., Gordeuk, V. R., & Saraf, S. L. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007980 · Cited by 7
“Vaso-occlusive episodes (preceding year)* 2 (1-5) 2 (0-4) 2 (0-4) .”
MethodSickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility
Tam, M. F., Tam, T. C. S., Simplăceanu, V., Ho, N. T., Zou, M., & Ho, C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658054 · Cited by 7
“However, homozygous individuals carrying only the Hb S genes develop hemolytic anemia (3,4).”
BackgroundПроданчук, М. Г., Tsatsakis, A. M., Prodanchuk, G. M., & Tsakalof, A. K. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.024 · Cited by 6
Cominetti, O., Smith, D. L., Hoffman, F., Jallow, M., Thézénas, M. L., Huang, H., Kwiatkowski, D. P., Maini, P. K., & Casals‐Pascual, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-31320-w · Cited by 6
The Role of Platelets in Sickle Cell Disease
Brzóska, T., Kato, G. J., & Sundd, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00031-x · Cited by 8
Pitanga, T. N., Santana, S. S., Zanette, D. L., da Guarda, C. C., Santiago, R. P., Maffili, V. V., Lima, J. B., Carvalho, G. Q., Ribeiro‐Filho, J., Ferreira, J. R. D., et al. (2021) · Inflammation Research · doi:10.1007/s00011-021-01461-2 · Cited by 8
Olaniyi, J. A., & ARINOLA, O. G. (2010) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-0901-30 · Cited by 7
Paluszkiewicz, A., Kellner, J., Elshehabi, M., & Schneditz, D. (2008) · ASAIO Journal · doi:10.1097/mat.0b013e318164dcc6 · Cited by 6
Hemolytic Anemia Associated Pulmonary Hypertension
Machado, R. F., & Gladwin, M. T. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-2246-6.50018-3 · Cited by 6
Self-citationSickle cell disease: Only one road, but different pathways for inflammation
Vilas-Boas, W., Cerqueira, B. A. V., Pitanga, T. N., Seixas, M. O., Menezes, J. F., Cajado, C., Adôrno, E. V., & Gonçalves, M. D. S. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.324071 · Cited by 6
“These effects, accordingly, are amplified on a chronic hemolytic and inflammatory disease, like HbSS, where the intravascular hemolysis contribute to release of cell free hemoglobin, heme and iron, consequently increase of oxygen radicals, limiting NO bioavailability, attracting more leukocytes, activating endothelial…”
Diagnostic et classification de l’hypertension pulmonaire
Montani, D., & Chaouat, A. (2010) · La Presse Médicale · doi:10.1016/s0755-4982(10)70002-6 · Cited by 6
Orekhova, N. A. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-1787-7 · Cited by 5
Silveira, T. H. R., Pereira, D. A., Pereira, D. A., Calmasini, F. B., Burnett, A. L. “., Costa, F. F., & Silva, F. H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1369120 · Cited by 5
Khadiri, C. E., Bokov, P., Dudoignon, B., Benzouid, C., Koehl, B., Hogan, J., & Delclaux, C. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf025 · Cited by 5
Volleman, C., Dubelaar, D. P. C., Phelp, P. G., Ibelings, R., Boer, A. M. T., Polet, C. A., van den Bergh, W. M., Vlaar, A. P. J., & van den Brom, C. E. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03251-3 · Cited by 6
“Firstly, CFHb causes increased vasoconstriction due to decreased bioavailability of nitric oxide [7, 8].”
Michel, C. P., Bendahan, D., Giannesini, B., Vilmen, C., Fur, Y. L., & Messonnier, L. A. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00333.2022 · Cited by 6
Zhang, M., Li, X., Lin, L., Shi, J., Luan, H., & Li, B. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116708 · Cited by 5
de Brito, P. L., Gushiken, L. F. S., Gotardo, É. M. F., Alberto, V. F., Leonardo, F. C., Becerra, A., Zamboni, D. S., Costa, F. F., & Conran, N. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00197.2025 · Cited by 6
Moosig, F., Reinhold‐Keller, E., Holl‐Ulrich, K., Feller, A. C., Bley, T. A., Holle, J. U., Zwerina, J., Lamprecht, P., Dalhoff, K., Venhoff, N., et al. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-012-0988-6 · Cited by 7
Sudden unexpected death in an undiagnosed sickle disease
Pillai, L. V., Husainy, S., Gosavi, S., & Vaidya, N. V. (2005) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.17096 · Cited by 5
Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar
Galiè, N., Hoeper, M. M., Humbert, M. J. C., Torbicki, A., Vachiéry, J., Barberà, J. A., Beghetti, M., Corris, P. A., Gaine, S., Gibbs, J. S. R., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73539-x · Cited by 8
Pritchard, K. A., Rivera, A., Hillery, C. A., & Brugnara, C. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.042 · Cited by 5
Ser/Thr protein kinase Bβ-NADPH oxidase 2 signaling in thromboinflammation
Li, J., & Cho, J. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000365 · Cited by 5
Proteomic analysis of serum samples of paracoccidioidomycosis patients with severe pulmonary sequel
dos Santos, A. R., Dionizio, A. S., Fernandes, M. D. S., Buzalaf, M. A. R., Pereira, B. A. S., Donanzam, D. D. F. A., Ribeiro, S. M., Paniago, A. M. M., Cavalcante, R. D. S., Mendes, R. P., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009714 · Cited by 8
Is hemolysis a novel therapeutic target in COVID-19?
Ousaka, D., & Nishibori, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956671 · Cited by 5
“Hemoglobin causes vasoconstriction via nitric oxide inactivation (1).”
BackgroundPrevention and Treatment of Transfusion Reactions
McMichael, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-0306-7.00062-3 · Cited by 8
Heme Protein Metabolism of NO and Nitrite
Kim‐Shapiro, D. B., & Gladwin, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00006-5 · Cited by 7
Self-citation
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.